Search

Author/Creator Spencer‐Green, George

1. A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. (29th April 2016)

Authors:
Cohen, Stanley; Emery, Paul; Greenwald, Maria; Yin, Donghua; Becker, Jean‐Claude; Melia, Lisa Ann; Li, Ruifeng; Gumbiner, Barry; Thomas, Dolca; Spencer‐Green, George; Meng, Xu
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 1(2016:Jul.)
Page Start:
129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparative assessment of clinical response in patients with rheumatoid arthritis between PF‐05280586, a proposed rituximab biosimilar, and rituximab. (22nd September 2016)

Authors:
Williams, Jason H.; Hutmacher, Matthew M.; Zierhut, Matthew L.; Becker, Jean‐Claude; Gumbiner, Barry; Spencer‐Green, George; Melia, Lisa A.; Liao, Kai‐Hsin; Suster, Matthew; Yin, Donghua; Li, Ruifeng; Meng, Xu
Journal:
British journal of clinical pharmacology
Issue:
Volume 82:Number 6(2016:Dec.)
Page Start:
1568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search